<VariationArchive VariationID="7615" VariationName="NM_000214.3(JAG1):c.2639_2640del (p.Asp879_Cys880insTer)" VariationType="Deletion" Accession="VCV000007615" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-30" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22654" VariationID="7615">
      <GeneList>
        <Gene Symbol="JAG1" FullName="jagged canonical Notch ligand 1" GeneID="182" HGNC_ID="HGNC:6188" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20p12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="10637684" stop="10673999" display_start="10637684" display_stop="10673999" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="10618331" stop="10654693" display_start="10618331" display_stop="10654693" Strand="-" />
          </Location>
          <OMIM>601920</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=JAG1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=JAG1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000214.3(JAG1):c.2639_2640del (p.Asp879_Cys880insTer)</Name>
      <CanonicalSPDI>NC_000020.11:10641824:ACA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20p12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="10641825" stop="10641826" display_start="10641825" display_stop="10641826" variantLength="2" positionVCF="10641824" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="10622473" stop="10622474" display_start="10622473" display_stop="10622474" variantLength="2" positionVCF="10622472" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1191" sequenceAccession="LRG_1191" change="g.37221_37222del">
            <Expression>LRG_1191:g.37221_37222del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1191t1" sequenceAccession="LRG_1191t1" change="c.2639_2640del">
            <Expression>LRG_1191t1:c.2639_2640del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1191p1" sequenceAccession="LRG_1191p1" change="p.Asp879_Cys880insTer">
            <Expression>LRG_1191p1:p.Asp879_Cys880insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.10622474_10622475del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.10622474_10622475del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.10641826_10641827del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.10641826_10641827del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007496.1" sequenceAccession="NG_007496" sequenceVersion="1" change="g.37221_37222del">
            <Expression>NG_007496.1:g.37221_37222del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000214.3" sequenceAccession="NM_000214" sequenceVersion="3" change="c.2639_2640del" MANESelect="true">
            <Expression>NM_000214.3:c.2639_2640del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000205.1" sequenceAccession="NP_000205" sequenceVersion="1" change="p.Asp879_Cys880insTer">
            <Expression>NP_000205.1:p.Asp879_Cys880insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601920.0001" DB="OMIM" />
        <XRef Type="rs" ID="1568792286" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000214.3(JAG1):c.2639_2640del (p.Asp879_Cys880insTer) AND Alagille syndrome due to a JAG1 point mutation" Accession="RCV000008054" Version="7">
        <ClassifiedConditionList TraitSetID="2076">
          <ClassifiedCondition DB="MedGen" ID="C1956125">Alagille syndrome due to a JAG1 point mutation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-22" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11180599</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9207787</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2076" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="142" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">JAG1-Related Alagille Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alagille syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEPATIC DUCTULAR HYPOPLASIA, SYNDROMATIC</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Alagille syndrome due to a JAG1 point mutation</ElementValue>
                <XRef ID="MONDO:0016862" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AHD</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AWS</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ALGS1</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability; this variability is seen even among individuals from the same family. The major clinical manifestations of ALGS are bile duct paucity on liver biopsy, cholestasis, congenital cardiac defects (primarily involving the pulmonary arteries), butterfly vertebrae, ophthalmologic abnormalities (most commonly posterior embryotoxon), and characteristic facial features. Renal abnormalities, growth failure, developmental delays, splenomegaly, and vascular abnormalities may also occur.</Attribute>
                <XRef ID="NBK1273" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17251" />
                <XRef ID="17251" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301450</ID>
                <ID Source="BookShelf">NBK1273</ID>
              </Citation>
              <XRef ID="261619" DB="Orphanet" />
              <XRef ID="52" DB="Orphanet" />
              <XRef ID="C1956125" DB="MedGen" />
              <XRef ID="MONDO:0016862" DB="MONDO" />
              <XRef Type="MIM" ID="118450" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28259" SubmissionDate="2013-03-28" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601920.0001_ALAGILLE SYNDROME 1" title="JAG1, 2-BP DEL, 3098GT_ALAGILLE SYNDROME 1" />
        <ClinVarAccession Accession="SCV000028259" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In their kindred C with Alagille syndrome (118450), Oda et al. (1997) demonstrated that the proband, her mother, and her sister had a frameshift in the JAG1 gene due to a 2-bp (GT) deletion in exon 22.</Attribute>
              <Citation>
                <ID Source="PubMed">9207787</ID>
              </Citation>
              <XRef DB="OMIM" ID="118450" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="JAG1" />
          </GeneList>
          <Name>JAG1, 2-BP DEL, 3098GT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 3098GT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601920.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALAGILLE SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4250917" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4959238|MedGen:C1956125" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002236630" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9207787</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11180599</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with clinical features of Alagille syndrome (PMID: 9207787). ClinVar contains an entry for this variant (Variation ID: 7615). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Cys880*) in the JAG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAG1 are known to be pathogenic (PMID: 11180599).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="JAG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.10622473_10622474del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1956125" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="28259" TraitType="Disease" MappingType="Name" MappingValue="ALAGILLE SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C1956125" Name="Alagille syndrome due to a JAG1 point mutation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4250917" TraitType="Disease" MappingType="XRef" MappingValue="C1956125" MappingRef="MedGen">
        <MedGen CUI="C1956125" Name="Alagille syndrome due to a JAG1 point mutation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

